OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
January 03, 2021
Despite the COVID-19 pandemic disruptions, with continued support and industry resilience, the European bio/pharma outlook for 2021 is positive.
The right partner can help companies overcome key formulation challenges for biologic drugs.
January 02, 2021
Positive regulatory developments are aiding the growth of the cannabis pharmaceuticals market, but more clinical data are needed to break the stigma and bring science to the fore.
EMA’s SPOR implementation guide version two is expected to be published soon, starting the countdown for companies to ensure their data-based submissions are compliant.
The outlook for the European pharma industry is appearing to be favourable overall.
December 02, 2020
Transparency and open-dialogue are vital to sway the vaccine-hesitant community.